GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1851 - 1875** of **4050** in total

« First

‹ Prev

…

71

72

73

74

75

76

77

78

79

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 3	-180	mild	G48898TH	59
IgM	Patient 3	-180	mild	G48898TH	105
IgA	Patient 3	4	mild	G48898TH	422
IgG	Patient 3	11	mild	G48898TH	65
IgG	Patient 3	4	mild	G48898TH	78
IgM	Patient 3	11	mild	G48898TH	188
IgM	Patient 3	4	mild	G48898TH	259
IgA	Patient 4	12	mild	G48898TH	424
IgG	Patient 4	12	mild	G48898TH	537
IgM	Patient 4	12	mild	G48898TH	229
IgA	Patient 1	10	moderate	G47566FL	392
IgA	Patient 1	22	moderate	G47566FL	442
IgA	Patient 1	6	moderate	G47566FL	351
IgG	Patient 1	10	moderate	G47566FL	43
IgG	Patient 1	22	moderate	G47566FL	56
IgM	Patient 1	10	moderate	G47566FL	44
IgM	Patient 1	22	moderate	G47566FL	161
IgA	Patient 2	15	mild	G47566FL	364
IgA	Patient 2	24	mild	G47566FL	407
IgG	Patient 2	15	mild	G47566FL	4857
IgG	Patient 2	24	mild	G47566FL	4947
IgM	Patient 2	15	mild	G47566FL	114
IgM	Patient 2	24	mild	G47566FL	124
IgG	Patient 1	6	moderate	G47566FL	42
IgM	Patient 1	6	moderate	G47566FL	40